*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
BIOeCON B.V.
|
|||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
(a) o
(b) o
|
|||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions): OO
|
|||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
||
6.
|
Citizenship or Place of Organization: The Netherlands
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
7. Sole Voting Power: 0
|
8. Shared Voting Power: 6,353,576 *
|
|
9. Sole Dispositive Power: 0
|
|
10. Shared Dispositive Power: 0
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 6,353,576 *
|
|||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
||
13.
|
Percent of Class Represented by Amount in Row (11): 12.42%*
|
|||
14.
|
Type of Reporting Person (See Instructions): CO
|
*
|
The amount of securities beneficially owned represents 6,353,576 shares of Class B Common Stock held by BIOeCON B.V. which are convertible into 6,353,576 shares of Class A Common Stock at any time, at the option of the holder. BIOeCON B.V. may be deemed to share voting power over these shares with Paul O’Connor, its managing director, BIOeCON Holding B.V., its controlling stockholder and BIOeCON International Holding N.V., the controlling stockholder of BIOeCON Holding B.V. Percentage ownership is calculated based on 51,173,595 shares of Class A Common Stock issued and outstanding, which is the sum of 45,169,877 Class A Common Stock shares as reported on the Form 10-Q filed by KiOR, Inc. with the Securities and Exchange Commission on August 14, 2012 and 6,003,718 Class A Common Stock shares distributed by BIOeCON B.V. as described herein.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
BIOeCON Holding B.V.
|
|||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
(a) o
(b) o
|
|||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions): N/A
|
|||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
||
6.
|
Citizenship or Place of Organization: The Netherlands
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
7. Sole Voting Power: 0
|
8. Shared Voting Power: 6,353,576 *
|
|
9. Sole Dispositive Power: 0
|
|
10. Shared Dispositive Power: 0
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 6,353,576 *
|
|||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
||
13.
|
Percent of Class Represented by Amount in Row (11): 12.42%*
|
|||
14.
|
Type of Reporting Person (See Instructions): CO
|
*
|
The amount of securities beneficially owned represents 6,353,576 shares of Class B Common Stock which are convertible into 6,353,576 shares of Class A Common Stock, held by BIOeCON B.V., of which BIOeCON Holding B.V. is a controlling stockholder and therefore may be deemed to share voting power with BIOeCON B.V. over the shares.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
BIOeCON International Holding N.V.
|
|||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
(a) o
(b) o
|
|||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions): N/A
|
|||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
||
6.
|
Citizenship or Place of Organization: Curacao, Netherlands Antilles
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
7. Sole Voting Power: 0
|
8. Shared Voting Power: 6,353,576 *
|
|
9. Sole Dispositive Power: 6,353,576 *
|
|
10. Shared Dispositive Power: 0
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 6,353,576 *
|
|||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
||
13.
|
Percent of Class Represented by Amount in Row (11): 12.42%*
|
|||
14.
|
Type of Reporting Person (See Instructions): CO
|
*
|
The amount of securities beneficially owned represents 6,353,576 shares of Class B Common Stock which are convertible into 6,353,576 shares of Class A Common Stock, held by BIOeCON B.V., of which BIOeCON International Holding N.V. controls as the controlling stockholder of BIOeCON Holding B.V. BIOeCON International Holding N.V. has sole dispositive power over the shares, and may be deemed to share voting power.
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):
Paul O’Connor
|
|||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions):
(a) o
(b) o
|
|||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions): N/A
|
|||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): N/A
|
o
|
||
6.
|
Citizenship or Place of Organization: The Netherlands
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
7. Sole Voting Power: 1,968,421 *
|
8. Shared Voting Power: 6,353,576 **
|
|
9. Sole Dispositive Power: 1,968,421 *
|
|
10. Shared Dispositive Power: 0
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 8,321,997
|
|||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): N/A
|
o
|
||
13.
|
Percent of Class Represented by Amount in Row (11): 16.26%
|
|||
14.
|
Type of Reporting Person (See Instructions): IN
|
*
|
The amount of securities beneficially owned represents 1,968,421 shares of Class A Common Stock owned by Paul O’Connor (including immediate family members who share the same household) acquired in a pro rata distribution of Class B Common Stock shares made by BIOeCON B.V. to the thirty-five ultimate beneficial owners of BIOeCON B.V., including Mr. O’Connor and his immediate family members.
|
**
|
The amount of securities beneficially owned represents 6,353,576 shares of Class B Common Stock which are convertible into 6,353,576 shares of Class A Common Stock, held by BIOeCON B.V., of which Paul O’Connor is the managing director and therefore may be deemed to share voting power with BIOeCON B.V. over the shares.
|